Pacific Biosciences, The Post-Hype Sleeper Of Genomics

Published: Mar 03, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Hype and biotech go hand in hand, but genomics takes exaggeration up a few extra notches. When genomics companies fail, they tend to crash especially hard. Yet every now and then, a company that’s monumentally hyped falls flat and then figures out a way to become a solid, if not spectacular, player. That’s the storyline that’s slowly taken shape at Pacific Biosciences. Menlo Park, CA-based PacBio (NASDAQ: PACB), readers may recall, had a few minutes of fame on Wall Street.

Help employers find you! Check out all the jobs and post your resume.

Back to news